ACXP
Price
$2.45
Change
+$0.12 (+5.15%)
Updated
Mar 28, 6:59 PM EST
41 days until earnings call
GLUE
Price
$7.05
Change
+$0.01 (+0.14%)
Updated
Mar 28, 6:59 PM EST
41 days until earnings call
Ad is loading...

Analysis and predictions ACXP vs GLUE

Header iconACXP vs GLUE Comparison
Open Charts ACXP vs GLUEBanner chart's image
Acurx Pharmaceuticals
Price$2.45
Change+$0.12 (+5.15%)
Volume$66.75K
CapitalizationN/A
Monte Rosa Therapeutics
Price$7.05
Change+$0.01 (+0.14%)
Volume$55.73K
CapitalizationN/A
View a ticker or compare two or three
ACXP vs GLUE Comparison Chart

Loading...

ACXPDaily Signal changed days agoGain/Loss if shorted
 
Show more...
GLUEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ACXP vs. GLUE commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACXP is a StrongBuy and GLUE is a Hold.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (ACXP: $2.45 vs. GLUE: $7.05)
Brand notoriety: ACXP and GLUE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACXP: 77% vs. GLUE: 73%
Market capitalization -- ACXP: $38.6M vs. GLUE: $353.59M
ACXP [@Biotechnology] is valued at $38.6M. GLUE’s [@Biotechnology] market capitalization is $353.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $570.99B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACXP’s FA Score shows that 1 FA rating(s) are green whileGLUE’s FA Score has 1 green FA rating(s).

  • ACXP’s FA Score: 1 green, 4 red.
  • GLUE’s FA Score: 1 green, 4 red.
According to our system of comparison, GLUE is a better buy in the long-term than ACXP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACXP’s TA Score shows that 5 TA indicator(s) are bullish while GLUE’s TA Score has 4 bullish TA indicator(s).

  • ACXP’s TA Score: 5 bullish, 3 bearish.
  • GLUE’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ACXP is a better buy in the short-term than GLUE.

Price Growth

ACXP (@Biotechnology) experienced а +18.93% price change this week, while GLUE (@Biotechnology) price change was -7.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.98%. For the same industry, the average monthly price growth was +8.91%, and the average quarterly price growth was +90.55%.

Reported Earning Dates

ACXP is expected to report earnings on May 09, 2024.

GLUE is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Biotechnology (+4.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ACXP with price predictions.
OPEN
A.I.dvisor published
a Summary for GLUE with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
GLUE($354M) has a higher market cap than ACXP($38.6M). GLUE YTD gains are higher at: 24.779 vs. ACXP (-36.031). ACXP has higher annual earnings (EBITDA): -14.58M vs. GLUE (-137.09M). GLUE has more cash in the bank: 232M vs. ACXP (7.47M). ACXP has less debt than GLUE: ACXP (66.5K) vs GLUE (46M). ACXP (0) and GLUE (0) have equivalent revenues.
ACXPGLUEACXP / GLUE
Capitalization38.6M354M11%
EBITDA-14.58M-137.09M11%
Gain YTD-36.03124.779-145%
P/E RatioN/A1.82-
Revenue00-
Total Cash7.47M232M3%
Total Debt66.5K46M0%
TECHNICAL ANALYSIS
Technical Analysis
ACXPGLUE
RSI
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
66%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
87%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 17 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
79%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
ACXPDaily Signal changed days agoGain/Loss if shorted
 
Show more...
GLUEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BDFUX29.290.15
+0.51%
Baron Discovery R6
LSLTX38.550.06
+0.16%
Leuthold Select Industries
GGRCX13.00N/A
N/A
Goldman Sachs Strategic Growth C
FSLEX35.46-0.01
-0.03%
Fidelity Environment & Alternative Engy
LGLUX40.38-0.05
-0.12%
Lord Abbett Growth Leaders R5

ACXP and

Correlation & Price change

A.I.dvisor tells us that ACXP and TSHA have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACXP and TSHA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACXP
1D Price
Change %
ACXP100%
+5.15%
TSHA - ACXP
26%
Poorly correlated
-9.46%
COGT - ACXP
26%
Poorly correlated
+3.07%
CRVO - ACXP
25%
Poorly correlated
+13.97%
BOLT - ACXP
24%
Poorly correlated
+13.11%
MNMD - ACXP
24%
Poorly correlated
-1.05%
More